News & Trends - MedTech & Diagnostics
Surgeons welcome ‘significant win’ for patients, amidst clash with health insurers
MedTech & Diagnostics News: The Royal Australasian College of Surgeons (RACS) is heralding a significant triumph for Australian patients following the federal government’s announcement that health insurers will remain obligated to cover the expenses of vital surgical items.
This announcement comes in the wake of concerted lobbying led by the RACS, alongside the Australian Private Hospitals Association (APHA), Medical Technology Association of Australia (MTAA) and Australian Medical Association (AMA). Health Minister Mark Butler’s confirmation of insurers’ responsibility to fund General Use Items (GUI) represents a shield for patients against out-of-pocket expenses, especially amidst the current surge in the cost of living.
Previously, a policy shift threatened to abolish mandatory coverage for General Use Items (GUI) such as sutures, staples, and sealants from July 1, 2024. This move could have precipitated either escalated gap fees for patients or heightened financial pressure on private hospitals.
“This decision is a significant win for Australians,” said Professor Mark Ashton, who is a member of the RACS Health Policy and Advocacy Committee. “It safeguards patients from additional financial stress when accessing essential surgical care.”
In response, Rachel David, CEO of Private Healthcare Australia, articulated, “What we have now is a funding system that is commercially driven where the incentive is to drive more volume growth of generic items that are already significantly overpriced in Australia vs world markets. Claims integrity of the Prescribed List (PL) items is now the priority.”
In a rebuttal, John Cunningham OAM, Spine Surgeon, retorted, “You’re the CEO of the organisation charged with representing private health insurance companies and protecting their profits.”
RACS has also been actively engaged in consultations with the government regarding reforms to the Prescribed List (previously Prostheses List). Over the past two years, the College has consistently underscored the significance of preserving access and options for commonly utilised surgical supplies.
“Our focus has been on ensuring these reforms don’t restrict access to essential items,” explained Professor Ashton. “We particularly cautioned against a ‘bundling’ model that could limit patient choice.”
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics
APAC medtech company scores TGA approval in heart disease
MedTech & Diagnostics News: An Asia Pacific medtech company has announced that its flagship drug-eluting stent (DES) has received regulatory […]
MoreNews & Trends - MedTech & Diagnostics
New state-based pilot to back home-grown medtech innovation
MedTech & Diagnostics: In a bid to enhance opportunities for local medtech manufacturers to sell to health services, a connected […]
MoreNews & Trends - Pharmaceuticals
Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis
Pharma News: Ferring Pharmaceuticals has announced results from a new study, which provides the first real-world evidence supporting the efficacy […]
MoreNews & Trends - Pharmaceuticals
Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives
Pharma News: Australian women are calling for more accurate information about their contraceptive options, with 70% feeling inadequately educated about […]
More